Columbia Laboratories Confirms FDA Denies Watson’s Appeal Related to Prochieve NDA for the Prevention of Preterm Birth

[at noodls] – LIVINGSTON, NJ – October 25, 2012 -Columbia Laboratories Inc. (Nasdaq:CBRX) today confirmed that the U.S. Food and Drug Administration (FDA) has denied Watson Pharmaceuticals’ (NYSE:WPI) Formal Dispute … more

View todays social media effects on CBRX

View the latest stocks trending across Twitter. Click to view dashboard